The expression of erythropoietin markers in the tumour cell in CCRCC as well as the involvement of HIF-2 in the carcinogenesis and the efficiency of HIF-2 antagonists in the treatment underscore the importance of identification of the cell of origin. This evidence concerns the gene EPO and neoplasm.